Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis
- PMID: 3018086
- DOI: 10.1111/1523-1747.ep12284061
Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis
Abstract
Since the biochemical events leading to cutaneous inflammation in atopic dermatitis and psoriasis are unknown, we studied the levels of arachidonic acid-derived mediators of inflammation as well as histamine in the suction blister fluid obtained from lesional and nonlesional skin of patients with these dermatoses. Mediator levels were determined radioimmunologically. Skin from healthy controls and uninvolved skin from patients contained very low or unmeasurable levels of the 5-lipoxygenase metabolite of arachidonic acid, leukotriene (LT) B4. In contrast, higher levels of LTB4-like immunoreactivity were detected in suction blister fluid from lesional atopic dermatitis skin, and even higher concentrations occurred in psoriasis lesions. LTB4-like immunoreactivity from atopic dermatitis suction blister fluid cochromatographed on reverse-phase high-pressure liquid chromatography with authentic LTB4, thus excluding cross-reaction of the LTB4-antibody with arachidonic acid or monohydroxyeicosatetraenoic acids. In contrast, suction blister concentrations of the cyclooxygenase metabolite of arachidonic acid prostaglandin (PG) E2 showed no significant differences between lesional and nonlesional patient skin and healthy control skin. PGD2 determined as a stable metabolite could not be detected in these samples. Histamine concentrations in lesional skin were within normal range. The elevated levels of the potent proinflammatory and immunomodulating mediator LTB4 could be involved in the pathogenesis of cutaneous inflammation in atopic dermatitis and psoriasis. In addition, they might explain the therapeutic efficiency of glucocorticosteroids, which among other actions inhibit the release of arachidonic acid from phospholipid stores by blocking the enzyme phospholipase A2. However, the specificity of disease expression in atopic dermatitis and psoriasis must be due to factors other than cutaneous LTB4 elevation.
Similar articles
-
Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations.J Allergy Clin Immunol. 1989 Feb;83(2 Pt 1):450-5. doi: 10.1016/0091-6749(89)90132-2. J Allergy Clin Immunol. 1989. PMID: 2537352
-
Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation.J Invest Dermatol. 1983 Jun;80(6):496-9. doi: 10.1111/1523-1747.ep12535038. J Invest Dermatol. 1983. PMID: 6343514
-
Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.Br J Clin Pharmacol. 1986 Dec;22(6):627-32. doi: 10.1111/j.1365-2125.1986.tb02949.x. Br J Clin Pharmacol. 1986. PMID: 3032226 Free PMC article.
-
Lipoxygenase products of arachidonic acid in psoriasis, atopic dermatitis, and experimental arthritis.Dan Med Bull. 1990 Aug;37(4):289-308. Dan Med Bull. 1990. PMID: 2123148 Review. No abstract available.
-
Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin.Arch Dermatol Res. 1988;280 Suppl:S33-41. Arch Dermatol Res. 1988. PMID: 2841909 Review.
Cited by
-
12/15-Lipoxygenase deficiency reduces densities of mesenchymal stem cells in the dermis of wounded and unwounded skin.Br J Dermatol. 2014 Jul;171(1):30-38. doi: 10.1111/bjd.12899. Epub 2014 Jul 17. Br J Dermatol. 2014. PMID: 24593251 Free PMC article.
-
In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORγt and IL-17.J Invest Dermatol. 2014 May;134(5):1276-1284. doi: 10.1038/jid.2013.526. Epub 2013 Dec 6. J Invest Dermatol. 2014. PMID: 24317395 Clinical Trial.
-
Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients.Arch Dermatol Res. 1991;283(2):77-80. doi: 10.1007/BF00371612. Arch Dermatol Res. 1991. PMID: 2069415
-
Transient Receptor Potential Channels and Itch.Int J Mol Sci. 2022 Dec 27;24(1):420. doi: 10.3390/ijms24010420. Int J Mol Sci. 2022. PMID: 36613861 Free PMC article. Review.
-
Current knowledge of the implication of lipid mediators in psoriasis.Front Immunol. 2022 Aug 26;13:961107. doi: 10.3389/fimmu.2022.961107. eCollection 2022. Front Immunol. 2022. PMID: 36091036 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical